WAM
ALNY icon

World Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

World Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$320K Sell
1,694
-160
-9% -$30K 0.03% 586
2021
Q2 		$314K Sell
1,854
-131
-7% -$19.2K 0.03% 653
2021
Q1 		$279K Sell
1,985
-156
-7% -$23.5K 0.03% 713
2020
Q4 		$278K Buy
2,141
+65
+3% +$8.68K 0.03% 678
2020
Q3 		$302K Buy
2,076
+17
+0.8% +$2.42K 0.03% 548
2020
Q2 		$305K Buy
2,059
+75
+4% +$10.1K 0.03% 526
2020
Q1 		$216K Sell
1,984
-898
-31% -$104K 0.02% 734
2019
Q4 		$332K Sell
2,882
-527
-15% -$52.5K 0.02% 764
2019
Q3 		$274K Buy
3,409
+219
+7% +$17.3K 0.01% 873
2019
Q2 		$231K Buy
3,190
+180
+6% +$13.8K 0.01% 983
2019
Q1 		$281K Buy
3,010
+78
+3% +$6.52K 0.01% 873
2018
Q4 		$214K Sell
2,932
-153
-5% -$11.8K 0.01% 915
2018
Q3 		$270K Buy
3,085
+99
+3% +$9.96K 0.01% 991
2018
Q2 		$294K Sell
2,986
-12
-0.4% -$1.19K 0.01% 968
2018
Q1 		$357K Sell
2,998
-696
-19% -$89.7K 0.02% 913
2017
Q4 		$469K Buy
3,694
+209
+6% +$26.3K 0.02% 905
2017
Q3 		$409K Buy
3,485
+14
+0.4% +$1.2K 0.01% 966
2017
Q2 		$277K Buy
+3,471
New +$222K 0.01% 1150
2015
Q2 		– Sell
-2,277
Closed -$238K – 1151
2015
Q1 		$238K Buy
2,277
+71
+3% +$7.2K 0.01% 1195
2014
Q4 		$214K Sell
2,206
-728
-25% -$67.4K 0.01% 1242
2014
Q3 		$229K Buy
+2,934
New +$189K 0.01% 1272
2013
Q4 		– Sell
-4,195
Closed -$269K – 1571
2013
Q3 		$269K Buy
+4,195
New +$209K 0.01% 1352

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

World Asset Management's ALNY Position: Q3 2021 in Review

World Asset Management reduced its Alnylam Pharmaceuticals (ALNY) stake by 8.6% in Q3 2021, selling an estimated $30K and leaving 1,694 shares worth $320K. The position accounts for 0.03% of the portfolio, ranked #586.

World Asset Management first reported a position in ALNY in Q3 2013 and has held it in 22 quarters since. The position peaked at $469K in Q4 2017. 405 funds tracked by Wall St. Rank hold ALNY as of Q3 2021.

  • World Asset Management held 1,694 shares of Alnylam Pharmaceuticals worth $320K as of Q3 2021.
  • World Asset Management sold 160 Alnylam Pharmaceuticals shares in Q3 2021, an estimated $30K.
  • Alnylam Pharmaceuticals made up 0.03% of World Asset Management's portfolio in Q3 2021, its #586 holding.
  • World Asset Management first reported a position in Alnylam Pharmaceuticals in Q3 2013 and has held it in 22 quarters since.
  • World Asset Management's Alnylam Pharmaceuticals position peaked at $469K in Q4 2017.
  • 405 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.